2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Systemic amyloidosis from A (AA) to T (ATTR): a review : A review on systemic amyloidosis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d1479148e182">Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by a different precursor protein which promotes amyloid formation and tissue deposition. Amyloidosis can be acquired or hereditary and can affect various organs, including the heart, kidneys, liver, nerves, gastrointestinal tract, lungs, muscles, skin and soft tissues. Symptoms are usually insidious and nonspecific resulting in diagnostic delay. The field of amyloidosis has seen significant improvements over the past decade in diagnostic accuracy, prognosis prediction and management. The advent of mass spectrometry-based shotgun proteomics has revolutionized amyloid typing and has led to the discovery of new amyloid types. Accurate typing of the precursor protein is of paramount importance as the type dictates a specific management approach. In this article, we review each type of systemic amyloidosis to provide the practitioner with practical tools to improve diagnosis and management of these rare disorders. </p>

          Related collections

          Author and article information

          Contributors
          Journal
          JOIM
          Journal of Internal Medicine
          J Intern Med
          Wiley
          09546820
          September 14 2020
          Affiliations
          [1 ]From the; Division of Hematology; Mayo Clinic; Rochester MN USA
          [2 ]Hematology Institute; Chaim Sheba Medical Center; Tel Hashomer Israel
          [3 ]Department of Cardiovascular Diseases; Mayo Clinic; Rochester MN USA
          [4 ]Department of Neurology; Mayo Clinic; Rochester MN USA
          [5 ]Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
          [6 ]Division of Nephrology and Hypertension; Mayo Clinic; Rochester MN USA
          Article
          10.1111/joim.13169
          32929754
          ac5a1990-3bd3-4094-a62d-351b2110dfd1
          © 2020

          http://doi.wiley.com/10.1002/tdm_license_1.1

          http://onlinelibrary.wiley.com/termsAndConditions#vor

          History

          Comments

          Comment on this article